Tofacitinib impurity V

Product Name
Tofacitinib impurity V
Chemical Name
Tofacitinib impurity V
Synonyms
Tofacitinib impurity V
CBNumber
CB64633642
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

Tofacitinib impurity V Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Tofacitinib impurity V Suppliers

China 10 India 1 United States 1 Global 12
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Country
United States
ProdList
14055
Advantage
65
S.Z. PhyStandard Bio-Tech. Co., Ltd.
Tel
0755-4000505016 13380397412
Fax
0755 28094224
Email
3001272453@qq.com
Country
China
ProdList
5047
Advantage
50
Nanjing XiZe Biotechnology CO., Ltd.
Tel
025-66023220 0086-15250997978
Fax
025-58362220
Email
1511893459@qq.com
Country
China
ProdList
7850
Advantage
55
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd
Tel
15850510341
Fax
025-85722793
Email
shiqingran@wzxchem.com
Country
China
ProdList
3713
Advantage
58
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD
Tel
0755-0755-0755-83725350 13380397412
Fax
0755-28094224
Email
3001280422@qq.com
Country
China
ProdList
10005
Advantage
58
Shanghai Botuo Biotechnology Co., LTD
Tel
16621358918
Fax
QQ:402135374
Email
botuopharma888@163.com
Country
China
ProdList
9208
Advantage
58
Shenzhen Excellent Biomedical Technology Co., Ltd.
Tel
18318671572
Email
2850803126@qq.com
Country
China
ProdList
4967
Advantage
58
ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel
18672472998
Email
sunchenjie@hdimpurity.com
Country
China
ProdList
6260
Advantage
58
ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel
+8618627948422
Email
sale@hdimpurity.com
Country
China
ProdList
3389
Advantage
58
More
Less

View Lastest Price from Tofacitinib impurity V manufacturers

ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
Tofacitinib Impurity V
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
0.98
Supply Ability
10g
Release date
2024-05-20

Tofacitinib impurity VRelated Search:

1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide (3S,4S)-Tofacitinib 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine Tofacitinib Impurity X Tofacitinib Impurity 6 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Tofacitinib Impurity 5 N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine Tofacitinib Impurity J Tofacitinib Impurity W Tofacitinib Impurity K

  • Tofacitinib impurity V